HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weight loss outcome after silastic ring Roux-en-Y gastric bypass: 8 years of follow-up.

AbstractBACKGROUND:
An underlying major aim of bariatric surgery is weight loss and its long-term maintenance. In spite of this, most studies regarding weight loss after surgical treatment of morbid obesity show 3-year follow-up results. We evaluated the effectiveness of silastic ring Roux-en-Y gastric bypass (SR-RYGBP) in promoting significant weight loss after an 8-year follow-up at the Londrina State University Hospital.
METHODS:
From May 1999 to December 2000, 211 morbidly obese patients were submitted to SR-RYGBP by the same surgical team. The study's design was longitudinal, prospective, and descriptive. The analysis of postoperative weight decrease was based on excess weight loss in percentage (%EWL) and the calculation of body mass index. Therapeutic failure was considered when patients lost <50% of excess weight.
RESULTS:
Patients lost to follow-up were 36.5%; therefore, 134 patients were included in this study. The average global EWL was 67.6 ± 14.9% on the first postoperative year, 72.6 ± 14.9% on the second year, 69.7 ± 15.1% on the fifth postoperative year, and 66.8 ± 7.6% on the eight postoperative year. Surgical treatment failure occurred in 15 patients (7.1%) over 8 years.
CONCLUSIONS:
SR-RYGBP was effective in promoting and maintaining weight loss in the long term with a low failure rate.
AuthorsAntonio Carlos Valezi, Jorge Mali Junior, Mariano Almeida de Menezes, Edivaldo Macedo de Brito, Shirley A F de Souza
JournalObesity surgery (Obes Surg) Vol. 20 Issue 11 Pg. 1491-5 (Nov 2010) ISSN: 1708-0428 [Electronic] United States
PMID20811958 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Gastric Bypass (methods)
  • Humans
  • Male
  • Middle Aged
  • Obesity, Morbid (surgery)
  • Prospective Studies
  • Prostheses and Implants
  • Treatment Outcome
  • Weight Loss
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: